                         SEQUENCE LISTING

<110>  University of Utah Research Foundation
 
<120>  THE USE OF SOLUBLE PRO(RENIN) RECEPTOR TO TREAT METABOLIC 
       DISORDERS AND RELATED CONDITIONS

<130>  21101.0344P1

<150>  62/471,140
<151>  2017-03-14

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  258
<212>  PRT
<213>  Homo sapiens

<400>  1

Ala Asn Glu Phe Ser Ile Leu Arg Ser Pro Gly Ser Val Val Phe Arg 
1               5                   10                  15      


Asn Gly Asn Trp Pro Ile Pro Gly Asp Arg Ile Pro Asp Val Ala Ala 
            20                  25                  30          


Leu Ser Met Gly Phe Ser Val Lys Glu Asp Leu Ser Trp Pro Gly Leu 
        35                  40                  45              


Ala Val Gly Asn Leu Phe His Arg Pro Arg Ala Thr Ile Met Val Thr 
    50                  55                  60                  


Val Lys Gly Val Asp Lys Leu Ala Leu Pro Thr Gly Ser Val Ile Ser 
65                  70                  75                  80  


Tyr Pro Leu Glu Asn Ala Val Pro Phe Ser Leu Asp Ser Val Ala Asn 
                85                  90                  95      


Ser Ile His Ser Leu Phe Ser Glu Glu Thr Pro Val Val Leu Gln Leu 
            100                 105                 110         


Ala Pro Ser Glu Glu Arg Val Tyr Met Val Gly Lys Ala Asn Ser Val 
        115                 120                 125             


Phe Glu Asp Leu Ser Val Thr Leu Arg Gln Leu Arg Asn Arg Leu Phe 
    130                 135                 140                 


Gln Glu Asn Ser Val Leu Asn Ser Leu Pro Leu Asn Ser Leu Ser Arg 
145                 150                 155                 160 


Asn Asn Glu Val Asp Leu Leu Phe Leu Ser Glu Leu Gln Val Leu His 
                165                 170                 175     


Asp Ile Ser Ser Leu Leu Ser Arg His Lys His Leu Ala Lys Asp His 
            180                 185                 190         


Ser Pro Asp Leu Tyr Ser Leu Glu Leu Ala Gly Leu Asp Glu Leu Gly 
        195                 200                 205             


Lys Arg Tyr Gly Glu Asp Ser Glu Gln Phe Arg Asp Ala Ser Arg Ile 
    210                 215                 220                 


Leu Val Asp Ala Leu Gln Lys Phe Ala Asp Asp Met Tyr Ser Leu Tyr 
225                 230                 235                 240 


Gly Gly Asn Ala Val Val Glu Leu Val Thr Val Lys Ser Phe Asp Thr 
                245                 250                 255     


Ser Leu 
        


